Comparing diffusion-weighted and T2-weighted MR imaging for the quantification of infarct size in a neonatal rat hypoxic–ischemic model at 24 h post-injury

PURPOSE: In a neonatal rat model of hypoxic-ischemic (HI) brain injury, using T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI), we aim to determine the best MRI method of lesion quantification that reflects infarct size. MATERIALS AND METHODS: Twenty 7-day-old rats underwent MRI 24h after HI brain injury was induced. Lesion size relative to whole brain was measured using T2WI and apparent diffusion coefficient (ADC) maps, applying thresholds of 60%, 70% and 80% contralateral control hemisphere mean ADC, and at day 10 post-HI on pathology with TTC staining. Multiple linear regression analysis was used to study the relationships between lesion size at MRI and pathology. RESULTS: Lesion size measurement using all MRI methods significantly correlated with infarct size at pathology; using T2WI, r=0.808 (p<0.001), using 80% ADC, 70% ADC and 60% ADC thresholds, r=0.888 (p<0.001), 0.761, (p<0.001) and 0.569 (p=0.014), respectively. Eighty percent ADC threshold was found to be the only significant independent predictor of final infarct volume (adjusted R(2)=0.775). CONCLUSION: At 24h post-HI, lesion size on DWI, using 80% ADC threshold is the best predictor of final infarct volume. Although T2WI performed less well, it has the advantage of superior spatial resolution and is technically less demanding. These are important considerations for experiments which utilize MRI as a surrogate method for lesion quantification in the neonatal rat HI model.     

表皮干细胞的快速高效分离

目的 寻找一种快递高效分离组织工程化皮肤种子细胞-皮肤干细胞的方法.方法 取成人手术切除之包皮,利用Ⅰ型胶原酶结合胰蛋白酶消化法,快速分离表皮干细胞,并对其进行鉴定及相关的生物学特性的研究.结果 应用Ⅰ型胶原酶结合胰蛋白酶,可在3小时内快速分离到表皮干细胞及成纤维细胞,经流式细胞仪及细胞免疫荧光鉴定,表皮细胞群体中角蛋白19(K19)阳性表达的细胞即表皮干细胞约占18%,但是其体外短期扩增仍较困难.结论 利用胶原酶消化法可在短期内高效分离到用于构建组织工程化皮肤的种子细胞,这为快速构建组织工程化皮肤提供了可能.     

对称性颅脑损伤的临床诊断与治疗(附123例报告)

目的提高治疗对称性颅脑损伤临床疗效。方法总结123例对称性颅脑损伤患者的临床资料,对其临床特点和治疗情况进行回顾性分析。结果预后良好64例(52.0%),中残25例(20.3%),重残8例(6.5%),植物生存4例(3.3%),死亡22例(17.9%)。结论对称性颅脑损伤是一种较为危重的特殊损伤类型,重视其临床特点,严密观察病情变化,正确把握治疗适应证,方可提高疗效。     

胆汁对豚鼠离体胆囊肌条收缩影响的实验研究

目的：观察不同浓度的胆汁对胆囊平滑肌运动的影响并初步探讨其作用机理。方法：将肌条置于离体平滑肌灌流肌槽内，用生理记录仪记录肌条的收缩活动。结果：(1)胆汁可降低离体胆囊肌条张力，减慢收缩频率，减小收缩波平均振幅。(2)心得安、L—NNA、六烃季胺可部分阻断胆汁对脂囊肌条的作用。结论：胆汁对豚鼠胆囊肌条的作用与肾上腺素能β受体、胆碱能N受体和N0有关。     

2型糖尿病患者高危因素分析

目的 分析2型糖尿病患者各种高危险因素控制状况及其与慢性并发症的关系。方法 记录464例50岁以上的2型糖尿病患者收缩压、舒张压、血脂、糖化血红蛋白和体质指数，按有无并发症分为两组进行分析。结果 有并发症组糖尿病病程、血压、总胆固醇、低密度脂蛋白胆固醇和血纤维蛋白原明显增高。Wald卡方分析显示糖尿病病程和收缩压有统计学意义。多数患者这些危险因素未得到很好的控制。结论 糖尿病患者存在着多种高危因素，有慢性并发症者更为严重，应注意综合治疗。     

人甲胎蛋白时间分辨免疫荧光分析试剂盒的研制

目的研制人甲胎蛋白(hAFP)时间分辨免疫荧光分析(TRFIA)试剂盒.方法采用双抗体夹心法建立AFP TRFIA 试剂盒,对试剂盒的各项指标进行评价.结果试剂盒的可测范围为l～1 000 U/ml,灵敏度为0.17 U/ml,精密度良好,批内和批间的精密度分别为3.3%～5.9%,3.7%～6.5%.与CEA、CA12-5、CA19-9、CA15-3、白蛋白无交叉反应.稳定性试验表明试剂可以在4℃稳定1年,37℃稳定7 d.426份正常血清标本测试该试剂盒的正常参考值范围是0～12 U/ml.用本试剂盒与国外同类试剂盒同时检测60份血清标本,其相关系数为0.995.结论试剂盒各项指标(灵敏度、精密度、特异性、稳定性、准确度)均达到临床检测要求,可替代国外同类产品试剂盒.     

体外胆管癌细胞x线照射后细胞周期及放射敏感性变化

目的 :探讨胆管癌细胞经x线照射后存活后代生长特性及放射敏感性的变化。方法 :人胆管癌细胞株和经x线照射后存活后代体外培养 ,测定其群体倍增时间、放射敏感性和细胞周期变化。结果 :胆管癌细胞的群体倍增时间为 (12 0 .0± 2 .8)h ,克隆形成率为 (14.0± 0 .6 ) %,放射敏感性参数SF2为0 .6 2± 0 .0 5。胆管癌细胞照射 6Gy后存活后代群体倍增时间为 (15 2 .8± 11.2 )h(t =3.12 4,P <0 .0 5 ) ,克隆形成率为 (6 .0± 0 .4) %(t=6 .5 2 2 ,P <0 .0 1) ,SF2为 0 .82± 0 .0 6 (t=2 .32 4,P <0 .0 5 )。胆管癌细胞x线照射后出现明显的S期细胞减少和G2 /M期阻滞 ,且有剂量依赖。结论 :胆管癌细胞x线照射后存活后代生长延缓 ,放射敏感性增高 ,呈S细胞减少和G2期阻滞。     

尿液分析标准化在临床上的应用

目的：建立尿液分析的标准化。方法：NCCLS和CCCLS推荐方法。结果：按标准化的要求进行尿液分析，以获得有临床价值的结果。结论：尿液分析是临床最常用的化验指标之一，在临床诊治疾病中起着非常重要的作用，因此在实际工作中必须遵照标准化的操作规程进行操作，更好地为临床服务。     

IMMUNOLOGICAL DIAGNOSIS OF LIGHT CHAIN DISEASE ANALYSIS OF 11 CASES FOUND IN FUJIAN PROVINCE

The present paper reports 11 cases of light chain disease (LCD) sequently found in several citles over Fujian province, Immunological classification of this group of LCD ww as follows: six of me cases belonged to type λ, four of them were type κ, and another one was a double LCD. We found that LCD was common in Fujlan only next to multiple myeloma (MM) of IgG class and accounted for 20% of the total 55 MM cases found in recent yean.It to well known that In matt patients of LCD M protein or Bence Jones proteinemia (BJPemia) to not detectable by conventional electro-phoresis. Our studies show that by making serum protein along with urinary BJP electrophoresis on the same one gel plate the sltuation can be greatly Improved It not only favour* the recognition of smail and faint band or bands of free light chain in serum, but also provides a repid and sensitive way, i. e. , immunofixation, to directly detect urinary light chain on the gel plate Immediately after electrophresis has been run.     

肝内HBcAg与血清学指标的关系及慢性乙型肝炎发病机理的探讨

We detected the presence and distribution of HBcAg in the liver by immunohistochemistry (ABC method) and the presence of HBV-DNA in serum (spot hybridization) and anti-HBe in serum (ELISA) from 59 cases of hepatitis B hospitalized in our hospital, including 47 cases of CAH, 5 cases of CPH, and 7 cases of subacute fulminant hepatitis. 1. HBcAg in the liver was detected in 25 out of 47 cases (53%) of CAH, in 2 out of 5 cases of CPH and in 4 out of 7 cases of subacute fulminant hepatitis. The total percentage was 53% (31/59). 2. There was no positive correlation between HBV replication activity and liver disease activity (P greater than 0.05). Our results did not support the hypothesis that suggests a direct cytopathic effect of HBV. Oppositely, the fact was that the presence, the amount and the patterns of HBcAg in the liver, and the presence of HBV-DNA in serum were predominant in mild CAH compared with those in severe CAH, predominant in CAH without cirrhosis compared with those in CAH with cirrhosis. There was a tendency of inverse correlation between HBV replication activity and liver disease activity. The results above were in line with the concept that HBcAg expressed on the surface of infected hepatocytes may be relevant target for T lymphocyte cytotoxicity. The results have suggested that an immune response to HBV is present, leading to the destruction of most infected cells. 3. There was a positive correlation between HBV-DNA in serum and HBcAg in the liver (P less than 0.005), indicating that HBV-DNA in serum can represent HBV replication.(ABSTRACT TRUNCATED AT 250 WORDS)